| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Qingyuan Sun, Jinyang Gao, Ran An, Menggeer Wang, Yanqing Wan. Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics. Journal of medical virology. vol 96. issue 4. 2024-04-15. PMID:38619024. |
probing molecular pathways: illuminating the connection between covid-19 and alzheimer's disease through the endocannabinoid system dynamics. |
2024-04-15 |
2024-04-17 |
Not clear |
| Hina Kanwal, Moris Sangineto, Martina Ciarnelli, Pasqualina Castaldo, Rosanna Villani, Antonino Davide Romano, Gaetano Serviddio, Tommaso Cassan. Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease. International journal of molecular sciences. vol 25. issue 7. 2024-04-13. PMID:38612861. |
potential therapeutic targets to modulate the endocannabinoid system in alzheimer's disease. |
2024-04-13 |
2024-04-15 |
mouse |
| Shlok Bodke, Nachiket Joshi, Rajasekhar Reddy Alavala, Divya Suare. In silico exploration of CB2 receptor agonist in the management of neuroinflammatory conditions by pharmacophore modeling. Computational biology and chemistry. vol 110. 2024-03-20. PMID:38507844. |
endocannabinoid system plays a pivotal role in controlling neuroinflammation, and modulating this system may not only aid in managing symptoms of neurodegenerative diseases such as alzheimer's disease, parkinson's disease, multiple sclerosis, epilepsy, central and peripheral neuropathic pain, but also, have the potential to target these diseases at an early-stage. |
2024-03-20 |
2024-03-23 |
Not clear |
| Barbara Broers, Federica Bianch. Cannabinoids for Behavioral Symptoms in Dementia: An Overview. Pharmacopsychiatry. 2024-03-06. PMID:38447959. |
cannabinoids might have a positive impact on amyloid formation in alzheimer's disease, the main form of dementia, and on bpsd symptoms. |
2024-03-06 |
2024-03-09 |
Not clear |
| Rebecca Ferrisi, Francesca Gado, Caterina Ricardi, Beatrice Polini, Clementina Manera, Grazia Chiellin. The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease. Journal of clinical medicine. vol 12. issue 23. 2023-12-09. PMID:38068253. |
the interplay between cannabinoid receptors and microglia in the pathophysiology of alzheimer's disease. |
2023-12-09 |
2023-12-17 |
Not clear |
| D Rapaka, P C Adiukwu, S R Challa, V R Bitr. Interplay Between Astroglial Endocannabinoid System and the Cognitive Dysfunction in Alzheimer's Disease. Physiological research. vol 72. issue 5. 2023-11-28. PMID:38015757. |
interplay between astroglial endocannabinoid system and the cognitive dysfunction in alzheimer's disease. |
2023-11-28 |
2023-12-07 |
Not clear |
| María Andrea Arnanz, Samuel Ruiz de Martín Esteban, Ana María Martínez Relimpio, Neta Rimmerman, Nurit Tweezer Zaks, María Teresa Grande, Julián Romer. Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease. Cannabis and cannabinoid research. 2023-10-20. PMID:37862567. |
effects of chronic, low-dose cannabinoids, cannabidiol, delta-9-tetrahydrocannabinol and a combination of both, on amyloid pathology in the 5xfad mouse model of alzheimer's disease. |
2023-10-20 |
2023-11-08 |
mouse |
| Mohammad Hosseininia, Fatemeh Rostami, Ladan Delphi, Zahra Ghasemzadeh, Fatemeh Kouhkan, Ameneh Rezayo. Memory impairment was ameliorated by corticolimbic microinjections of arachidonylcyclopropylamide (ACPA) and miRNA-regulated lentiviral particles in a streptozotocin-induced Alzheimer's rat model. Experimental neurology. 2023-10-02. PMID:37783412. |
the present study aimed to investigate the effect of corticolimbic cannabinoid cb1 receptors activity on memory impairment in the intracerebroventricular (icv)-streptozotocin (stz) animal model of alzheimer's like-disease. |
2023-10-02 |
2023-10-07 |
rat |
| Victor Voicu, Felix-Mircea Brehar, Corneliu Toader, Razvan-Adrian Covache-Busuioc, Antonio Daniel Corlatescu, Andrei Bordeianu, Horia Petre Costin, Bogdan-Gabriel Bratu, Luca-Andrei Glavan, Alexandru Vlad Ciure. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules. vol 13. issue 9. 2023-09-28. PMID:37759788. |
special emphasis is placed on the role of cannabinoids in neurodegenerative diseases, showcasing their potential benefits in conditions such as alzheimer's disease, parkinson's disease, huntington's disease, and multiple sclerosis. |
2023-09-28 |
2023-10-07 |
human |
| Beatriz Pacheco-Sánchez, Rubén Tovar, Meriem Ben Rabaa, Lourdes Sánchez-Salido, Antonio Vargas, Juan Suárez, Fernando Rodríguez de Fonseca, Patricia River. Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer's Disease: Implications for Controlling Astroglial Activity. International journal of molecular sciences. vol 24. issue 16. 2023-08-26. PMID:37628778. |
sex-dependent altered expression of cannabinoid signaling in hippocampal astrocytes of the triple transgenic mouse model of alzheimer's disease: implications for controlling astroglial activity. |
2023-08-26 |
2023-09-07 |
mouse |
| Carla Fonseca, Miren Ettcheto, Joana Bicker, Maria José Fernandes, Amílcar Falcão, Antoni Camins, Ana Fortun. Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy? Ageing research reviews. 2023-07-06. PMID:37414155. |
under the umbrella of depression and alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy? |
2023-07-06 |
2023-08-14 |
Not clear |
| Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, Cristina Rosell-Valle, Makoto Shimozawa, Gefei Chen, Fernando Rodríguez de Fonseca, Per Nilsson, Simone Tambar. The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer's Disease in Biology. vol 12. issue 6. 2023-06-28. PMID:37372090. |
the expression of the endocannabinoid receptors cb2 and gpr55 is highly increased during the progression of alzheimer's disease in the endocannabinoid system (ecs) and associated lipid transmitter-based signaling systems play an important role in modulating brain neuroinflammation. |
2023-06-28 |
2023-08-14 |
Not clear |
| Juyong Kim, Pilju Choi, Young-Tae Park, Taejung Kim, Jungyeob Ham, Jin-Chul Ki. The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer's Disease-like Mouse Model. International journal of molecular sciences. vol 24. issue 7. 2023-04-13. PMID:37047798. |
the cannabinoids, cbda and thca, rescue memory deficits and reduce amyloid-beta and tau pathology in an alzheimer's disease-like mouse model. |
2023-04-13 |
2023-08-14 |
mouse |
| Mohd Amir Kamaruzzaman, Muhammad Hibatullah Romli, Razif Abas, Sharmili Vidyadaran, Mohamad Taufik Hidayat Baharuldin, Muhammad Luqman Nasaruddin, Vishnumukkala Thirupathirao, Sreenivasulu Sura, Kabul Warsito, Nurul Huda Mohd Nor, Muhammad Amsyar Azwaruddin, Mohammed Abdullah Alshawsh, Mohamad Aris Mohd Mokla. Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies. Frontiers in pharmacology. vol 14. 2023-03-24. PMID:36959856. |
regulatory role of the endocannabinoid system on glial cells toward cognitive function in alzheimer's disease: a systematic review and meta-analysis of animal studies. |
2023-03-24 |
2023-08-14 |
Not clear |
| Marzie Khavandi, Praveen P N Rao, Michael A Beazel. Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity. International journal of molecular sciences. vol 24. issue 2. 2023-01-21. PMID:36674424. |
the regulation and metabolism of the endocannabinoid system has received extensive attention for their potential neuroprotective effect in neurodegenerative diseases such as alzheimer's disease (ad), which is characterized by amyloid β (aβ) -induced cell toxicity, inflammation, and oxidative stress. |
2023-01-21 |
2023-08-14 |
mouse |
| Alana C Costa, Helena P G Joaquim, João F C Pedrazzi, Andreia de O Pain, Gustavo Duque, Ivan Aprahamia. Cannabinoids in Late Life Parkinson's Disease and Dementia: Biological Pathways and Clinical Challenges. Brain sciences. vol 12. issue 12. 2022-12-23. PMID:36552056. |
these findings suggest a potential therapeutic role of cannabinoids to neurodegenerative disorders such as parkinson's disease (pd) and alzheimer. |
2022-12-23 |
2023-08-14 |
Not clear |
| Alana C Costa, Helena P G Joaquim, João F C Pedrazzi, Andreia de O Pain, Gustavo Duque, Ivan Aprahamia. Cannabinoids in Late Life Parkinson's Disease and Dementia: Biological Pathways and Clinical Challenges. Brain sciences. vol 12. issue 12. 2022-12-23. PMID:36552056. |
some clinicians consider cannabinoids an alternative for older adults bearing parkinson's disease and alzheimer's dementia with a poor response to first-line treatments. |
2022-12-23 |
2023-08-14 |
Not clear |
| Henry Blanton, P Hemachandra Reddy, Khalid Benama. Chronic pain in Alzheimer's disease: Endocannabinoid system. Experimental neurology. 2022-12-01. PMID:36455638. |
chronic pain in alzheimer's disease: endocannabinoid system. |
2022-12-01 |
2023-08-14 |
Not clear |
| Eduarda Dal Pisol Schwab, Ruliam Queiroz, Anne Karine Bosetto Fiebrantz, Murilo Bastos, Juliana Sartori Bonini, Weber Cláudio Francisco Nunes da Silv. Hypothesis on ontogenesis and pathophysiology of Alzheimer's disease. Einstein (Sao Paulo, Brazil). vol 20. 2022-11-30. PMID:36449761. |
some factors, such as excitotoxicity, cholinergic dysfunctions, oxidative stress, tau protein hyperphosphorylation, changes in amyloid-beta peptide metabolism, herpes viruses, apolipoprotein e, glycogen synthase kinase 3, insulin resistance, and the endocannabinoid system seem to be related to pathophysiology of alzheimer's disease. |
2022-11-30 |
2023-08-14 |
Not clear |
| Itziar Terradillos, Itziar Bonilla-Del Río, Nagore Puente, Maitane Serrano, Amaia Mimenza, Leire Lekunberri, Ilazki Anaut-Lusar, Leire Reguero, Inmaculada Gerrikagoitia, Samuel Ruiz de Martín Esteban, Cecilia J Hillard, María T Grande, Julián Romero, Izaskun Elezgarai, Pedro Grande. Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease. Glia. 2022-11-28. PMID:36437738. |
altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of alzheimer's disease. |
2022-11-28 |
2023-08-14 |
mouse |